Monday, June 16, 2014

Biodefense Q&A: PositiveID's (OTCBB: PSID) Chairman and CEO Discusses Progress with Bio-Threat Detection Technology and Revenue Guidance

New York, NY - June 16, 2014 (Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveID Corporation (OTCBB: PSID), a developer of biological detection and diagnostics solutions. Mr. Caragol discusses the current status and opportunities for its bio-threat detection technology and recently announced revenue guidance.

Q: Investorideas.com
On May 27 th you released a corporate update on your contracts for M-BAND and Firefly technologies. Can you give investors the highlights?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
We are very proud of what we have achieved so far in 2014. Our major accomplishments include forming significant partnerships with commercial and federal government organizations, and importantly, revenue generation. In summary, we entered into a contract with a large commercial partner to support a U.S. Department of Defense (“DoD”) contract and test our M-BAND system, which will provide revenue to the Company of $841,000 through September; we announced one of our teaming partners was awarded a prime contract by the U.S. Defense Threat Reduction Agency to conduct research and development to combat weapons of mass destruction; and, more recently, we signed a Space Act Agreement with NASA’s Ames Research Center through which NASA will assess our Firefly technology for potential ground and space applications. When you look back at our releases, the commercial and government partners we are working with are a true “who’s who” in the fields of security and detection.
Q: Investorideas.com
At this point do you see more interest in your M-BAND or Firefly Technologies for contracts and revenue streams and can you give some insight as to why?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
We continue to see interest in both M-BAND and Firefly. M-BAND, which stands for Microfluidic Bio-agent Autonomous Networked Detector, has more of a targeted, albeit significant, opportunity through anticipated multi-billion dollar government programs to detect airborne biological weapons of mass destruction. On the other hand, we believe Firefly, our point-of-need, handheld, molecular diagnostic device, will be able to be used in a multitude of industries, including military/government applications, healthcare and even agricultural applications. As you might expect, these are very large markets as well.
Q: Investorideas.com
Your latest press release on June 11th announced your first ever revenue guidance of $4-10 million. You also stated that $3.3 million is backlogged. This is obviously a transitional period for the company in several ways. Are you starting to see a perception change from the financial community?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
I think we are. We are seeing more interest from strategic partners who see the potential of our products and the markets we are pursuing. The fact that we are generating revenue from a large commercial partner under a government contract and technology license is also noteworthy. We have the ability to execute, our technology and IP portfolio is strong, and we believe we have the partners in place to win major contracts.
Q: Investorideas.com
As a small company receiving contracts from large government agencies including U.S. Department of Defense, U.S. Department of Homeland Security, and Department of Health and Human Services do you attribute your success to the technology or your partnering or both?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
I think our partners are a direct reflection of the quality and differentiators of our technology and the strength and experience of our management team. We are very gratified by the partnerships we’ve established and believe they provide an important validation of what PositiveID has to offer.
Q: Investorideas.com
In May you announced signing a Space Act Agreement with NASA's Ames Research Center to collaborate on testing the Company's Firefly Dx detection system ("Firefly") as a platform for biological research and commercial development for ground and space applications. Can you give our readers the significance of this collaboration and what it means moving forward?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
When an organization with the respect and recognition that NASA has earned wants to work with you and further the development of your technology to see how it may help them in their specific endeavors, it is significant. As we pursue opportunities with other government and commercial entities, having a group like NASA standing by our side makes people take notice. Having third-party support, especially when it comes from a group of world-class scientists, is very important for a small company like PositiveID.
Q: Investorideas.com
In closing, it seems like the company and technology are gaining momentum and traction from some very high profile institutions and agencies; do you think that is a reflection of a renewed sense of urgency to address bio-threats or is it a matter of going through the system and reaping the long term rewards?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
Unfortunately, we’ve witnessed global events that underscore the danger posed by biological weapons of mass destruction. That said, there definitely is a heightened focus on the need for bio-threat detection, and a pick-up in government procurements for these technologies. At the same time, however, it’s not simply a matter of being in the right place at the right time. We have worked diligently to create the necessary partnerships to successfully capture the opportunities ahead of us.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples. For more information on PositiveID, please visit http://www.PositiveIDCorp.com .
Contact
PSID: 
Allison Tomek 
561-805-8000 
atomek@positiveidcorp.com
InvestorIdeas.com is a global news source and research resource covering leading sectors including defense and biodefense, social media, tech, biotech, water, mining and energy.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for free news alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp . Disclosure: Investorideas has been previously compensated by PSID in the form of cash and 144 restricted shares for participation in the security conference in March plus news p;ublication.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Statements about PositiveID's future expectations, including without limitation, the likelihood that PositiveID will generate revenue of $4-10 million over the next 18 months, $3.3 million of which is already in backlog; the likelihood that Firefly will be able to be used in a multitude of industries, including military/government applications, healthcare and even agricultural applications; the likelihood that PositiveID has the partners in place to win major contracts; the likelihood that PositiveID has created the necessary partnerships to successfully capture the opportunities ahead of it; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including the likelihood that PositiveID will be successful with its submissions for bids and proposals in conjunction with several large commercial partners in response to a pick-up in new U.S. government procurements for bio-threat detection, and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 11, 2014, and 10-Qs filed on May 20, 2014, November 19, 2013, and August 14, 2013, as amended August 19, 2013, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Friday, June 13, 2014

Tech Media News: NXT-ID (OTCQB: NXTD) Demo's Wocket™ Smart Wallet Financial Transaction

SHELTON, Conn. - June 13, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD), a biometric authentication company focused on the growing m-commerce market, releases a video of the next generation smart wallet, Wocket™, designed to replace all the cards in your wallet, executing a financial transaction.

Mr. Gino Pereira, CEO of NXT-ID, Inc. explains step-by-step how to make a Wocket transaction:
"All your important personal information is secured on a tamper-proof encrypted chip on your Wocket, so if you were to lose your wallet, there is no payment information available to be stolen. Using your Wocket is simple:
1. To access a card for payment, you would first verify your identity by using a spoken password (Wocket recognizes your voice), or by entering a PIN or image on the touch screen.
2. Touch the drop-down menu at the top left of the screen. You will see a list of categories such as debit, credit, loyalty etc. and select the appropriate category.
3. Choose the card you wish to use on the touchscreen and remove the WocketCard from your Wocket.
4. Swipe your WocketCard as you would any regular credit card.
Wocket is also capable of producing a "wocket number" which is a one-time use encrypted card number to prevent skimming attacks and protect your private card information. This technology can also be applied to online transactions, making card processing much more secure using today's existing payment infrastructure."
See demo video at https://www.youtube.com/watch?v=EMUpEMv9O2Y
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices.
Wocket™ is a next generation smart wallet designed to replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
The Wocket retails for $149.99. Advance order a Wocket at: http://www.wocketwallet.com/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Thursday, June 12, 2014

WOCKET LAUNCHES INTO WAITING MARKET; NXT-ID (OTCQB:NXTD) Company Update by SOUNDVIEW RESEARCH

June 12, 2014 (Investorideas.com Newswire) Summary: The WocketTM was officially launched on May 28th at the Plaza Hotel in NYC. All the feedback we received from attending suggests that consumers who get a chance to see and understand it, immediately want one. It’s a viable way to deliver something consumers can use as a digital wallet that is secure, private, and able to handle all their payment, identification, and loyalty needs. The Wocket is really a wallet replacement, and the functional demonstration worked very well. We’ll be monitoring the progress and consumer reaction very closely over the next few months with an eye to validating our IV model, which currently suggests a stock value of $11.70/share. We have also extended our forecast to arrive at a projected IV in 2015 of $20.55.
Additional Details: As a prelude to what will be a more active marketing phase, the event included attendance by the media, investors, analysts, and Miss Universe 2012, which added a special level of energy and media attention.
Investorideas.com Newswire
Former Miss Universe 2012, Olivia Culpo, displays the Wocket
In addition to elaborating on the key features, there was a live demonstration of using the Wocket to do a typical transaction by swiping the card, just as one does with a standard plastic debit or credit card.
Online preorders are available with first units shipping to consumers in September at a price of $149.99, plus some optional services for customers that require additional protection.
Wocket is NXT-ID’s replacement for a conventional wallet. The heart of it is the device itself which securely stores cards digitally – that covers virtually all of the important cards consumers carry in a wallet today, including credit, debit, ATM, loyalty, gift, ID, membership, insurance, medical information, and coupons. Wocket locks a user’s private information in an electronic "vault" where only an authenticated owner can authorize access to the data. The case provides some space for cash and a driver’s license.
As concerns continue to mount in the U.S. and around the world about identity theft and data hacking, the timing of the launch of the Wocket helps NXT-ID channel media attention into their marketing strategy. The Wocket addresses the important issues not adequately addressed currently by smart phones and other mobile devices.
The biggest advantages are in authentication and security. The Wocket uses biometric technology to provide identity protection and security. All information used with the Wocket is encrypted by the owner’s personal biometric stamp. NXT-ID is a pioneer in biometric technology, and the Wocket incorporates some of the most advanced biometric technology on the market (see our report, "Mobile Security Beyond the Password, for an in depth discussion of the technology). The device protects whatever information is stored in it so that it cannot be released to any other individual or device without the user’s permission.
All payment cards and other dynamic stripe cards are swiped directly into the Wocket during the initial set-up process. Barcodes and text, such as voter’s registration, loyalty and/or membership cards, may all be scanned or entered into the Wocket. All information is encrypted by the owner’s personal biometric stamp and can be accessed via a low power touch screen or optionally, a voice command.
Information is placed on a tamper-proof encrypted chip inside the Wocket rather than on anywhere in the cloud. Any attempt to access the encrypted chip will result in destroying any information stored on it.
If a Wocket or Wocket card is stolen, the company can guarantee that the Wocket is worthless to anyone besides its owner. The security technology incorporated by the Wocket zeroes out any relevant information on the card dynamically after each use. Hence, the card used with the Wocket becomes a blank piece of plastic to a thief. For added peace of mind, NXT-ID will be offering customers an insurance plan for stolen, misplaced, or lost Wockets.
Investorideas.com Newswire
The Wocket Smart Wallet
The Wocket can securely store up to 10,000 items including – debit/credit/loyalty/gift cards, health information, coupons, and miscellaneous records.
Battery life is expected to be one year or more, depending on frequency of use. A light will appear on the device weeks before the battery is due for replacement, so users can replace the conventional lithium ion battery that is widely available at a variety of retail stores around the world.
NXT-ID has an FAQ section on the Wocket website that addresses key questions and issues associated with the device (see: http://wocketwallet.com/).
NXT-ID has started taking pre-orders for the Wocket on their website, with plans to ship the first devices in September. Unlike many digital devices on the market today, the Wocket is being manufactured in America. NXT-ID is planning a significant promotional campaign this summer to increase customer awareness and drive more pre-sales.
Sales Projections and Intrinsic Valuation: Over the past year we’ve seen plenty of data showing that there is strong desire for a device like the Wocket. Consumers are still waiting for an actual product to buy and use. Initial sales volumes will depend on initial orders, and initially, on the ability of NXT-ID to ramp production and manage some longer lead time components.
After a review of our current projections and intrinsic valuation (IV) model, we don’t see anything that needs to be changed. However, extending the projections and model out an additional year allows us to publish a 2015 IV estimate of $20.55.
Our current estimate for sales in 2014 is 40K units, which grow fast in later years to reach nearly 1M units in 2018 and 1.5M units in 2019. These unit projections are still very low considering the small penetration rate needed to generate those numbers. If the Wocket is successful, unit growth can be much faster. Many investors were surprised by how quickly new categories like the iPad reached large numbers of units after consumer adoption. We won’t have any real visibility on these longer term projections until 2015, but have a credible working forecast to start with.
Although digital currencies are not the initial focus for the Wocket, we were impressed with the figures showing consumer adoption of bitcoin wallets grew from under 500K to over 5M in one year!
Investorideas.com Newswire
Conclusion: The official launch of the Wocket has certainly increased our confidence in the IV model shown below. As consumers begin to use the device in the real world, we’ll know much more.
There’s huge demand to use digital payments and have a secure digital wallet that is easy to use and genuinely safe. Consumers are nearly clamoring for it. Although other companies have done Kickstarter campaigns and showed slick videos, the NXT-ID Wocket will be helping to define this market in the next few months.
The stock has been holding steady after a major post-IPO run, but our IV clearly shows there is far more to go if the Wocket is delivered on time and consumers have a good experience with it.
Investorideas.com Newswire ABOUT SOUNDVIEW RESEARCH

SoundView conducts independent research in emerging technologies. Our approach is to combine major thematic forces where technology is involved and use analysis to identify the most promising companies and investment opportunities.
Our business model is combination of advisory fees, subscriptions and shared revenue agreements. We measure our success by the quality of our analysis, accuracy of the conclusions and the size and influence of our audience. We apply our own proven approach to valuation that we call intrinsic value (IV) for informing investment decisions and optimizing portfolio management.
IMPORTANT DISCLOSURES
1. The analysts who prepared this report certify that the content expresses accurately their personal views and opinions about the subject companies and securities. The analysts have not been and will not be receiving direct or indirect compensation for expressing the specific views or conclusions in this report.
2. Except where otherwise noted, clients or affiliates of SoundView Research may own positions in the securities mentioned and/or provide, have provided or may provide advisory services to some of the companies mentioned.
3. SoundView Research does not provide investment advice in the form of "buy," "sell," or "hold" ratings. This report is intended strictly for informational purposes. We make no claims as to the completeness or accuracy of this report although we have done our best. We do not undertake to advise you of any changes in our opinion or information contained herein.
4. SoundView is NOT a registered securities broker/dealer, investment bank nor investment advisory.
5. SoundView Technology Group does receive advisory fees, has vested interests and/or may have embedded biases in our work. However our aim is on what we call "fact-based research" and providing a balanced and informed analysis that provides illumination and insight for investors.
6. SoundView Research is solely responsible for all content– whether it is created for a third party, part of an advisory engagement or simply an expression of our ongoing research and analysis. We exercise final editorial control over all content produced and any mistakes, omissions or errors are our own.
Our research is distributed to institutions, investors, company managers and individuals via proprietary platforms1 and via the internet and social networks. We embrace the online community and social and professional networks to engage with colleagues, clients and investors.
SoundView maintains additional online brands for specialty research products including IPO Candy, Dealipedia and Research 2.0. We also collaborate and share with research partners like GigaOM.
CONTACT INFORMATION
Main Address: SoundView Technology Group, 1313 Washington St., 326, Boston MA 02118 Phone: 617-828-6462 Website: http://www.soundview.co
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Wednesday, June 11, 2014

Breaking Tech News: SoundView Technology Group Issues NXT-ID (OTCQB: NXTD) Update Following Wocket Smart Wallet Launch Event

BOSTON - June 11, 2014 (Investorideas.com Newswire) We attended the NXT-ID (OTCQB: NXTD) Wocket(TM) smart wallet launch event in NYC on May 28th and were pleased with the number of features present in the device demonstrated and encouraged by early consumer reaction to the Wocket.

Just one week later we heard Rudy Giuliani talk about how cyber crime has reached "crisis proportions" because "all our sensitive data is in the cloud for criminals to access." His sentiment helps explain why a secure device like the Wocket will be a preferred solution for sensitive financial and other key data.
NXT-ID is offering pre-orders for the Wocket smart wallet (www.wocketwallet.com) at $149 and the first shipments to customers are planned for late September. After a review we are keeping our 2014 forecast of 40,000 units and will be evaluating consumer response in order to validate our longer term projects.
We're also introducing a longer term intrinsic value (IV) estimate of $20.55 for 2015. With a current IV estimate of $11.70 we think growth investors will find the risk/reward of this situation to be attractive.
We previously stated in a prior update, " We believe in the digital conversion of our "wallet" over time and know that mobile devices alone won't be the answer for many years due to power limits, lack of privacy and security concerns. Nobody knows if the NXT-ID Wocket is going to be "the one" but we do know that so far it's the most well designed product we have seen that is coming to market this year."
Our NXT research update (PDF) is available here: http://s3.amazonaws.com/Published_Research/NXT-ID_NXTD_Update_Note_Final_June_2014.pdf
COMPANY OVERVIEW
NXT-ID is an emerging technology company that is building an innovative, next generation information security platform using advanced biometric technology to enable secure transactions, identity management, and access control via mobile and other devices in an intuitive, cost-effective and easy-to-use manner. Led by CEO Gino Pereira and CTO David Tunnell, the company has three distinct lines of business: law enforcement, m-commerce, and biometric access control application.
"NXT-ID is creating a new paradigm for information security beyond the password that is based on innovative biometric technology."
Past reports and related research can be found on our website at http://soundview.co/infosec.
Disclosure: SoundView Technology Group is providing fee-based advisory services to NXT-ID on investment positioning, strategy and business development. Our research opinions are our own and based as much as possible on factual information and observations. Additional information about SoundView can be found at http://soundview.co.
Kris Tuttle
SoundView Technology Group
kris@soundview.co
+1-617-828-6462

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Tuesday, June 10, 2014

Breaking Tech News: Offer to Purchase Limited Edition Wocket™ Smart Wallet to NXT-ID (OTCQB: NXTD) Shareholders Expires June 15th

SHELTON, Conn. - June 9, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the growing m-commerce market, reports the offer to purchase a limited edition, "Signature," Wocket smart wallet to shareholders, will expire on Monday, June 16th. Wocket™ is a next generation smart wallet, designed to replace all the cards in your wallet.

"The shareholder version will differentiate from the first consumer edition," said Mr, Gino Pereira, CEO of NXT-ID, Inc. "It will include a unique home button featuring the new corporate logo. The special button will be retired after this edition. And most importantly to collectors, it will be a numbered limited edition."
He went on to say, "To purchase the 'Signature' Wocket, one can simply visit the website (http://wocketwallet.com/) and check the drop-down box for the, 'Signature Edition (Shareholders Only)' option. We now accept all payment options, including: Visa, MasterCard, American Express and PayPal. We will confirm the shareholder position with our transfer agent and it will be shipped with the first product run estimated in September."
Wocket is currently priced at $149.99.
Shareholders of record owning 100 shares or more as of May 23rd, 2014 that advance order, and pay for, a Wocket on the website www.wocketwallet.com before the end of the day on June 15th, 2014 will be issued the special limited "Signature" edition Wocket.
NXT-ID is currently launching an online digital marketing campaign for its smart wallet, Wocket™. At the recent Plaza press conference in May, Mr. Gino Pereira stated this was in addition to the recent CNBC ads and part of an ongoing effort, "to make Wocket a household name."
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
Advance ordering is available at http://www.wocketwallet.com/
The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Breaking Tech News: More Protection with NXT-ID's (OTCQB: NXTD) Wocket™ Smart Wallet; Securely Store All Your Passwords in Your Own Personal Vault

SHELTON, Conn. - June 10, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the growing mobile commerce market, revealed today its Wocket™ Smart Wallet will include a password storage feature, further demonstrating the versatility of Wocket™ to store and protect a wide range of private information. With this password list feature, Wocket™ owners can store and securely access all their login credentials such as usernames and passwords on a Wocket™ in addition to payment, loyalty, identity and other cards typically held within a wallet. Users will soon be able to utilize Wocket™ for secure, biometrically locked, password storage in lieu of similar online solutions where data is at risk.

"Passwords continue to be a difficult issue for consumers. 2013 was clearly the "Year of Personal Data Breach", with 110 million credit and debit card account numbers lost to hackers by Target alone," says David Tunnell, CTO of NXT-ID. "Heartbleed and other security vulnerabilities demonstrate the need for a new method for consumer's to protect their private data. Users all over the world utilize online password storage services to store thousands of passwords behind one master password. If a hacker were to gain access to that one master password, they would gain access to all the user's passwords. That is the root of the problem with online storage of private data."
Wocket™ enables users to store and encrypt their passwords locally, and securely inside their own smart wallet. Wocket™ owners will also be able to store other sensitive information such as Social Security Numbers and insurance cards on Wocket™ instead of online servers and applications where their identity is potentially vulnerable.
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
Advance ordering is available at http://www.wocketwallet.com/
The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, the Company's securities.
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-Id renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Medical Technology News: Medical Technology The Role of Aethlon Medical (OTCQB: AEMD) in the Emerging Immuno-Oncology Market; Q&A with Aethlon Chairman and CEO, Jim Joyce

Point Roberts, WA, NEW YORK, NY - June 10, 2014 (Investorideas.com newswire) Investorideas.com, a global news source covering leading sectors including biotech and medical technology issues a Q&A interview with Mr. James A. Joyce ,Chairman and CEO of Aethlon Medical, Inc. (OTCBB:AEMD).

Q: Investorideas.com
How did Aethlon Medical become involved in cancer research?
A: James A. Joyce, Chairman, CEO
Several years ago, we made a bet that particles known as exosomes, were released by tumors to suppress the immune system of cancer patients. We believed that exosomes triggered the death of the immune cells you need to combat cancer. That cancer deployed exosomes as a mechanism to survive and proliferate. It is important to recognize that when we initiated our exosome research programs, the medical community viewed these particles as nothing more than cellular debris with no biological function.
Our second bet was that our Hemopurifier, the same Hemopurifer that has been utilized in the treatment of HIV and hepatitis c infected individuals, could capture tumor-secreted exosomes underlying a wide range of cancers. As it turns out, we were right on both accounts. Exosomes suppress the immune system and can be captured by our Hemopurifier. As a result, we are positioned to address a significant unmet medical need in cancer care. However, to leverage our opportunity in cancer we needed a market for immune-based therapies to emerge. Fortunately, the growing interest in immune-based therapies has now triggered an Immuno-Oncology industry explosion.
Q:Investorideas.com
Can you describe the Immuno-Oncology industry?
A: James A. Joyce ,Chairman, CEO
The Immuno-Oncology industry is based on therapies that augment or train the immune system to better combat cancer. The long-term goal of the Immuno-Oncology industry is to eliminate the need for toxic chemotherapy and radiation in cancer care. In fact, I suspect mankind will someday look back in disbelief at the barbaric use of chemo and radiation. Regardless, huge bets are being made that Immuno-Oncology will revolutionize the cancer field. Analysts at Citigroup predict the Immuno-Oncology market, which basically didn't exist two years ago, will reach $35 billion per year. This prediction is further reinforced by the fact that Merck, Bristol-Myers, AstraZeneca and Roche alone have already initiated more than 78 immune-based clinical studies.
Q:Investorideas.com
What Immuno-Oncology role do you feel Aethlon Medical will play?
A: James A. Joyce ,Chairman, CEO
We believe Hemopurifier therapy should play a central role in the Immuno-Oncology marketplace. Especially if you consider that as a device, our Hemopurifier can be combined to improve the benefit of other therapies without adding drug toxicity. It's not hard to envision that the elimination of tumor-secreted exosomes from circulation would improve the ability for immune-based drugs to combat cancer. From a mechanistic standpoint, combining a drug that stimulates the immune response with a device that inhibits immune-suppression would seem to be the perfect therapeutic marriage.
Q:Investorideas.com
Why are tumor-secreted exosomes an important cancer therapy target?
A: James A. Joyce ,Chairman, CEO
Last month, researchers from Harvard, Massachusetts General and Oxford published an article that discussed why tumor-secreted exosomes are cancer therapy targets. The article referenced the current knowledge that exosomes promote cancer progression by suppressing the immune system. However, that's just the beginning as the researchers also pointed to evidence that exosomes trigger resistance to drug therapies, that they play a role in allowing tumors to create their own blood supply for survival, and that they are seeds that allow for the creation and spread of cancer metastasis. The article also validated another original belief of ours; that the level of tumor-secreted exosomes in circulation correlates with the stage of cancer progression. In other words, if you don't have cancer, tumor-secreted exosomes won't be present. However, if you have advanced-stage cancer, they will be present in massive quantities. Based on this knowledge, it’s possible that circulating exosome load will someday become an industry standard for monitoring cancer progression in much the same way circulating viral load is the standard for monitoring infectious disease progression. Regardless, the article only referenced one company with a therapeutic strategy to address tumor-secreted exosomes. That was Aethlon Medical. Oh, and by the way, the authors of the article were sponsored by the National Cancer Institute.
Q:Investorideas.com
Is there anything else about tumor-secreted exosomes that we should know?
A: James A. Joyce ,Chairman, CEO
Yes, tumor-secreted exosomes have been discovered to transport PD-1, which is perhaps the most important target of drug companies advancing immuno-oncology therapies. In fact, the latest scientific literature seems to suggest that exosomes may be providing a transport mechanism for many pharmaceutical industry targets as a means for them to proliferate below the surveillance of the immune system.
Q:Investorideas.com
Based on the opportunity in cancer care, are you moving away from the infectious disease market?
A: James A. Joyce ,Chairman, CEO
The rapidly emerging opportunity in cancer allows us to expand the utility of Hemopurifier therapy. It does not replace our infectious disease endeavors, which is evidenced by plans to launch the first FDA approved study of Hemopurifier therapy in hepatitis c (HCV) patients. We believe that drug resistance and viral mutation will continue to drive opportunities for us in the HIV and HCV space and we also recognize that the proven broad-spectrum capabilities of Hemopurifier therapy provides a backdrop to address viral pathogens that remain untreatable with drug or vaccine therapies. However, I won't be surprised if it’s our ability to capture tumor-secreted exosomes that drives broad awareness of Hemopurifier therapy among both the medical and investment community.
About Aethlon Medical .( OTCBB:AEMD ).and Jim Joyce:
Aethlon Medical creates therapeutic devices to address infectious disease, cancer and other life-threatening conditions. The Company's lead product is the Aethlon Hemopurifier®, an extracorporeal device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes. Jim Joyce is the founder, Chairman and CEO of Aethlon Medical.
http://www.aethlonmedical.com/
About Investorideas.com ( www.investorideas.com )
InvestorIdeas.com is a global news source and research resource covering leading sectors including medical technology, biotech, defense, water, mining and energy.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for free news alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Disclosure: AEMD subscribes to the Investorideas newswire content publishing annual program ( 9700 per Year, paid quarterly) for news publishing .
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Contact Investorideas.com 800 665 041

Monday, June 09, 2014

Biotech News Alert: SUNSHINE BIOPHARMA'S (OTCQB: SBFM) Adva-27a FEATURED IN 2014 WORLDWIDE UTERINE CANCER REPORT FOR ITS EFFECTIVENESS AGAINST MULTIDRUG RESISTANT UTERINE CANCER CELLS

Montreal, Quebec, Canada - June 9, 2014 (Investorideas.com Biotech Newswire) Sunshine Biopharma, Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that Adva-27a, the Company’s flagship oncology drug candidate was featured in Global Markets Direct: Uterine Cancer - Pipeline Review, H1 2014 Report for its effectiveness against multidrug resistant uterine cancer cells in vitro.

The Global Markets Direct Uterine Cancer Report provides comprehensive information on the therapeutic development for Uterine Cancer, with comparative analysis, therapeutics assessment, mechanism of action, route of administration and molecule type.  The Report also reviews key players involved in the therapeutic development for Uterine Cancer including Sunshine Biopharma Inc.
In December 2012, Sunshine Biopharma announced that it had achieved dramatic effects in Uterine Cancer using its Adva-27a compound. The studies were carried out in MES-SA/Dx5, a Uterine Sarcoma cell line that has become multidrug resistant through the use of a commonly administered chemotherapy drug, Doxorubicin.  Adva-27a was able to efficiently kill these cells with an IC50 of less than 8 micromolar, a pharmacologically very favorable drug concentration.
In addition to Uterine Cancer, Adva-27a has been shown to be effective at killing multidrug resistant Breast Cancer cells, Small-Cell Lung Cancer cells and Pancreatic Cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012).
Sunshine Biopharma recently reported that it has initiated the construction of mouse xenograft models for Pancreatic Cancer as part of the plans of positioning Adva-27a for clinical development for Pancreatic Cancer in parallel with the previously announced multidrug resistant Breast Cancer indication. The first U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.
"We are very pleased that this testing indicated that our drug, Adva-27a, is effective against Uterine Cancer," said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma. "In the U.S. alone, over 52,000 new cases of Uterine Cancer are diagnosed each year. "We are anxious to begin our clinical studies soon and look forward to the opportunity of providing a new treatment for Uterine Cancer patients worldwide," he added.
About The Global Markets Direct: Uterine Cancer - Pipeline Review, H1 2014 Report
The following links provide more information about the Global Markets Direct: Uterine Cancer - Pipeline Review, H1 2014:
http://www.globalmarketsdirect.com/Report.aspx?ID=Uterine-Cancer-Pipeline-Review-H1-2014&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare
http://www.researchandmarkets.com/research/9bk98l/uterinecancer
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant Breast Cancer cells, Small-Cell Lung Cancer cells, Uterine Sarcoma cells and Pancreatic Cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935. The Company is planning a Phase I clinical trial of Adva-27a for Pancreatic Cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug resistant Breast Cancer to be conducted at McGill University's Jewish General Hospital in Montreal (Canada).
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Thursday, June 05, 2014

Tech News Alert: Security and Convenience in the Payment Industry; CEO's of Dwolla and NXT-ID's (OTCQB: NXTD) Wocket™ Share How They Plan to Revolutionize the Sector

New York, NY - Point Roberts, WA - June 5, 2014 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including mobile payments and payment technologies, issues a report on emerging payment technology companies Dwolla and NXT-ID, Inc. Recently, InvestorIdeas attended both the Cartes Conference held in Las Vegas and the NXT-ID, Inc.( OTCQB: NXTD ) Wocket™ smart wallet press conference held at the Plaza Hotel in New York, gaining insight on how the CEO’s of the two companies are taking a very different approach towards solving the same problem; security in the payment industry.

The ongoing breaches that consumers and businesses are faced with daily, such as those that affected Target and eBay, have incited the birth of new technologies including mobile apps, internet and cloud solutions and new digital wallets.They are all looking to protect our identity and make our financial transactions secure .
CEO and Founder Ben Milne of Dwolla said at Cartes, “We set money free.”
The Company website says “We're not like those other big payment companies that rely on plastic cards and charge hefty fees. Instead, we’ve built our own network that securely connects to your bank account and allows you to move money for just $0.25 per transaction, or free for transactions $10 or less.”
At the Cartes conference he told a captive audience, “We literally took everything the card does and built it into a protocol and just replaced the card and with it a whole lot of problems go out the door. This is not a philosophical idea, this has actually been built and being distributed. We are currently integrated with governments, businesses and even banks. Some regulated entities and publicly traded companies utilize our network on a daily basis and it’s all without a card !”
So Dwolla aims to eliminate our plastic cards - while newcomer NXT-ID, Inc. wants to replace all the cards in your wallet (up to 10,000 if you have them) with one biometrically secure card and a Wocket™ smart wallet.
Mr. Gino Pereira, Chief Executive Officer of NXT-ID started his presentation at the Plaza by stating "Meet Wocket, the smartest wallet you will ever own."
“In the last 18 months there have been a billion breaches of private information. One in ten of us have had our identity stolen. What can we actually do about this? It turns out that 44% of identity fraud can be traced to a stolen wallet or purse. If we can do something about protecting the information in our wallets, then we can cut down tremendously on the incidents of identity fraud. That’s why you need a Wocket.”
He went on to explain, “You can store 10,000 pieces of information on here in your own personal vault, It can only be accessed by you, by your voice biometrically or with a PIN, or by drawing a shape on a screen. You can store all your loyalty cards, gift cards, credit cards, on a slim, easy to use device. We think this is the evolution of smart . You started with smart phones, you then had smart watches; this is a smart wallet.”
“When you select a card that you want to use on your Wocket touchscreen, it gets programmed on the Wocket card and you hand the Wocket card to your server or attendant and they will check you out just like with any other credit card. Bu it’s on one single card! For security, the information that is transferred onto the card is erased or zeroized a very short time after it is charged.”
He closed with “This is the Wocket™, it retails for $149.99 and it’s available at www.wocketwallet.com” , followed by a public demonstration of the first financial transaction with a Wocket™.
According to a recent report from Business Intelligence, “The credit card companies themselves aren’t going anywhere for now. Visa and MasterCard in particular will remain an indispensable part of the chain because they don’t actually process payments. They simply provide the rails that the credit card system runs on. Credit card processors like First Data that actually do the work of processing merchants’ credit card transactions on the back-end are also in a strong position.”
So what is the future of payments; one card, no card? “One thing we know is the way we do it today is not ideal”, said Ben Milne of Dwolla.
Mr. Gino Pereira, Chief Executive Officer of NXT-ID quoted well-known scientist Alan Kay during his presentation reminding us, “The best way to predict the future is to invent it.”
See the Videos:
Video Clip of CEO and Founder Ben Milne of Dwolla in Las Vegas May 14th, 2014:
http://www.youtube.com/watch?v=bDmZWxbrZHM

Video of Mr. Gino Pereira, Chief Executive Officer of NXT-ID at Plaza Hotel in New York City May 28 th
http://youtu.be/joOi60S6LCk

About Dwolla
Dwolla is a payment network that allows any business or person to send, request and accept money. We're not like those other big payment companies that rely on plastic cards and charge hefty fees. Instead, we’ve built our own network that securely connects to your bank account and allows you to move money for just $0.25 per transaction, or free for transactions $10 or less. https://www.dwolla.com/
About NXT-ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/ , http://3d-id.net/
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including mobile, tech and biometric stocks.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our online stock directories to research stocks – including biometric and mobile payment stocks http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of June 2014, NXT-ID renewed for five thousand per month and average of two thousand five hundred 144 shares (cash equivalent) for news publication and marketing of Wocket smart wallet. More info: http://www.investorideas.com/About/Disclaimer.asp   and http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 -   Source – www.Investorideas.com